MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $137,000 | -6.2% | 600,000 | 0.0% | 0.00% | – |
| Q4 2022 | $146,000 | -37.1% | 600,000 | 0.0% | 0.00% | – |
| Q3 2022 | $232,000 | -36.1% | 600,000 | 0.0% | 0.00% | – |
| Q2 2022 | $363,000 | +0.3% | 600,000 | 0.0% | 0.00% | – |
| Q1 2022 | $362,000 | -77.4% | 600,000 | 0.0% | 0.00% | -100.0% |
| Q4 2021 | $1,602,000 | -3.3% | 600,000 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $1,656,000 | -3.2% | 600,000 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $1,710,000 | -16.9% | 600,000 | 0.0% | 0.00% | -66.7% |
| Q1 2021 | $2,058,000 | +29.9% | 600,000 | 0.0% | 0.00% | +50.0% |
| Q4 2020 | $1,584,000 | -15.4% | 600,000 | 0.0% | 0.00% | -33.3% |
| Q3 2020 | $1,872,000 | -24.5% | 600,000 | 0.0% | 0.00% | -25.0% |
| Q2 2020 | $2,478,000 | +156.5% | 600,000 | 0.0% | 0.00% | +100.0% |
| Q1 2020 | $966,000 | -35.1% | 600,000 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $1,488,000 | +47.6% | 600,000 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $1,008,000 | -77.6% | 600,000 | -66.7% | 0.00% | -33.3% |
| Q2 2019 | $4,500,000 | +144.3% | 1,800,000 | +200.0% | 0.00% | 0.0% |
| Q1 2019 | $1,842,000 | +16.3% | 600,000 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $1,584,000 | -4.5% | 600,000 | +55.8% | 0.00% | 0.0% |
| Q3 2018 | $1,659,000 | +62.0% | 385,000 | +48.1% | 0.00% | +50.0% |
| Q2 2018 | $1,024,000 | +406.9% | 260,000 | +170.4% | 0.00% | – |
| Q4 2017 | $202,000 | -34.0% | 96,170 | -15.8% | 0.00% | -100.0% |
| Q3 2017 | $306,000 | – | 114,225 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|